Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05083156 · ClinicalTrials.gov registry record

Cow's Milk Elimination for Treatment of Eosinophilic Esophagitis

A clinical trial of Eosinophilic Esophagitis, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

Active
Registry status
54
Enrollment target
1
Study location

NCT05083156: Active study of Eosinophilic Esophagitis, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

NCT05083156 is a study of Eosinophilic Esophagitis that is active but no longer recruiting, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 54 participants, below the 863-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05083156, a study of Eosinophilic Esophagitis, is active but no longer recruiting, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

ACTIVE NOT RECRUITING
Registry status
54 participants
Enrollment target
1
Study location

Study Summary

The investigators seek to assess the efficacy of removing cow's milk from an EoE patient's diet. This will be determined by esophageal inflammation and clinical and histological response to the milk elimination treatment.

Primary Outcome

Participants who have eliminated cow's milk will be clinically assessed to determine if histological remission, measured by Eos/hpf, was induced under this diet for children with EOE

Conditions Studied

Interventions

  • OTHER Diet Change

Study Locations (1)

Illinois

  • Ann & Robert H Lurie Childjren's Hospital of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2012-03
Est. Completion 2025-12

What the registry record for NCT05083156 still lists

NCT05083156 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 863-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 1 intervention - of which Diet Change is the first listed.

NCT05083156 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT05083156 about?

NCT05083156 is a clinical study titled "Cow's Milk Elimination for Treatment of Eosinophilic Esophagitis". The investigators seek to assess the efficacy of removing cow's milk from an EoE patient's diet. This will be determined by esophageal inflammation and clinical and histological response to the milk elimination treatment.

What is the current status of trial NCT05083156?

This trial is currently active not recruiting. The enrollment target is 54 participants. The study started on 2012-03. Estimated completion is 2025-12.

What conditions does trial NCT05083156 study?

This clinical trial studies the following conditions: Eosinophilic Esophagitis.

What interventions are being tested in trial NCT05083156?

The interventions under investigation include: Diet Change (OTHER).

Who is sponsoring clinical trial NCT05083156?

This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05083156 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Eosinophilic Esophagitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05083156's enrollment target sits among peer trials

54 27th of 44 higher than 17 of 44 other Eosinophilic Esophagitis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Eosinophilic Esophagitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01269853 · 54 participants · Phase 1

    Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

  • NCT02390752 · 54 participants · Phase 1

    Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

  • NCT02991248 · 54 participants · NA

    Improve Dynamic Lateral Balance of Humans With SCI

  • NCT02993900 · 54 participants · NA

    Image-Guided Gynecologic Brachytherapy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT05083156, the US trial registry maintained by the National Library of Medicine. NCT05083156 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.